effect shown in highly selected subgroups of patients cannot, however, be extrapolated to other groups of patients, although other studies, including those with a wider, less selected population,9 12 indicate that even low-risk patients may profit from long-term beta-adrenoceptor blockade.
Case reports
Case 1-A 61-year-old man with a remote anteroseptal myocardial infarction presented with recurrent sustained ventricular tachycardia. A week before admission a permanent ventricular pacemaker had been inserted for transitory complete heart block. Electrocardiography showed right bundlebranch block, left posterior hemiblock, and evidence of an old anteroseptal infarction. When not paced his rhythm was sinus with first-degree atrioventricular block. Comprehensive intracardiac electrophysiological study disclosed a corrected sinus node recovery time of 220 ms (normal < 525 ms), A-H interval 120 ms (normal 60-140 ms), and H-V interval 85 ms (normal 30-55 ms). Two morphologically distinct types of ventricular tachycardia could be induced. Quinidine, procainamide, propranolol, digoxin, disopyramide, mexiletine, and several combinations of these failed to suppress the tachycardia. Amiodarone 600 mg daily was started. Six weeks later ventricular extrastimulation induced poorly tolerated ventricular tachycardia. In the meantime no spontaneous ventricular tachycardia had occurred and ambulatory electrocardiography showed complete suppression of ventricular ectopic activity. At that time no sinus node activity was present and the patient was pacemaker-dependent without an escape focus. Apart from amiodarone the only known cardioactive agents that he was taking were metoprolol and digoxin, both in conventional dosage and for several months before these studies. Electrolyte concentrations were normal. The patient was discharged taking these agents as no non-pharmacological treatment was indicated.
Case 2-A 67-year-old man with a history of myocardial infarctions in 1968 and 1977 presented with recurrent drug-resistant ventricular tachycardia that required numerous cardioversions. He was in congestive cardiac failure and had severe peripheral vascular disease and mild chronic renal failure. Electrocardiography showed normal sinus rhythm with an intraventricular conduction defect and evidence of old anteroseptal and inferior infarctions.
Electrophysiological study showed a corrected sinus node recovery time of 270 ms, A-H interval 125 ms, and H-V interval 80 ms. Sustained ventricular tachycardia (160/min) was induced by ventricular extrastimulation. Serial drug testing with many agents failed to suppress his arrhythmia. Treatment was initiated with amiodarone 1 g daily. Ventricular ectopy was suppressed, and nine days later repeat ventricular stimulation disclosed inducible ventricular tachycardia (125/min). Amiodarone was continued, and two days later the patient was in slow junctional rhythm (35 beats/min), hypotensive, and poorly perfused. He responded promptly to ventricular pacing. At the time his other treatment included digoxin, frusemide, and isosorbide dinitrate. There was no electrolyte abnormality. No rise in enzyme activity occurred, and his serum digoxin concentration was 2 2 mg/l. Amiodarone was withdrawn and intermittent sinus node activity returned next day; within two days periods of normal sinus rhythm were noted. Spontaneous ventricular tachycardia requiring cardioversion recurred, however, so an atrioventricular sequential pacer was inserted and amiodarone reinstituted. As no other treatment was suitable for this patient he was discharged with this regimen.
Comment
Sinus bradycardia and sinoatrial block have been described as side effects of amiodarone,' but to our knowledge sinus arrest has not been reported and no such case has been notified either to Sanofi Inc, the US agent for the manufacturers of the drug, or to the Food and Drug Administration. Both patients had normal sinus node automaticity as shown by corrected sinus node recovery times within the normal range, this being considered the best available test of sinus node automaticity and possibly of overall node function.4
Amiodarone depressed automaticity by inhibiting phase 4 depolarisation in the sinus node of rabbits in vitro,5 and these observations suggest that such a mechanism may account for this potentially lethal complication in susceptible patients.
